Live
- Govt plans to establish offshore Johns Hopkins University Campus in India
- Goa Aces clinch Indian Racing League title
- Study finds how hormone therapy can reshape the skeleton
- High-street fashion players looking at India for manufacturing: Report
- Shreyas Iyer to lead Mumbai as Prithvi Shaw returns for Syed Mushtaq Ali Trophy
- 'Failed to resolve crisis': NPP withdraws support from BJP govt in Manipur
- Chennai: Actress Kasturi Remanded in Custody Until 29th of This Month
- Aaqib Javed likely to become Pakistan's new white-ball head coach
- BJP panel to draft poll charge sheet against AAP govt in Delhi
- Allu Arjun Thanks Fans in Patna, Teases 'Pushpa 2' Release
Hope to resolve issues faced by Indians vaccinated with Covishield travelling to EU soon: Poonawalla
Serum Institute of India CEO Adar Poonawalla (Photo | PTI)
Vaccine major Serum Institute of India chief executive officer Adar Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon.
NEW DELHI: Vaccine major Serum Institute of India chief executive officer Adar Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon.
Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.
"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.
As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford).
The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson).
